Keywords: آسیب پایه; AT; ataxia telangiectasia; ATLD; ataxia-telangiectasia-like disorder; ATM; ataxia telangiectasia mutated; BBC3; B-cell lymphoma/leukemia 2 binding component 3; BD; base damage; BLM; Bloom; BRCA1/2; breast cancer susceptibility gene 1/2; CCNB1; cyclin B1;